Publication: Polyfunctional HIV-1 specific response by CD8+ T lymphocytes expressing high levels of CD300a
dc.contributor.author | Vitallé, Joana | |
dc.contributor.author | Terrén, Iñigo | |
dc.contributor.author | Gamboa-Urquijo, Leire | |
dc.contributor.author | Orrantia, Ane | |
dc.contributor.author | Tarancón-Díez, Laura | |
dc.contributor.author | Genebat, Miguel | |
dc.contributor.author | Leal, Manuel | |
dc.contributor.author | Ruiz-Mateos, Ezequiel | |
dc.contributor.author | Borrego, Francisco | |
dc.contributor.author | Zenarruzabeitia, Olatz | |
dc.contributor.authoraffiliation | [Vitallé,J; Terrén,I; Gamboa-Urquijo,L; Orrantia,A; Borrego,F; Zenarruzabeitia,O] Biocruces Bizkaia Health Research Institute, Immunopathology Group, Barakaldo, Spain. [Tarancón-Díez,L; Genebat,M; Leal,M; Ruiz-Mateos,E] Clinic Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital, University of Seville, CSIC, Seville, Spain. [Tarancón-Díez,L] Laboratory of Molecular Immuno-Biology, Gregorio Marañón University Hospital, Health Research Institute, Madrid, Spain. [Leal,M] Internal Medicine Service, Santa Ángela de la Cruz Viamed Hospital, Sevilla, Spain. [Borrego,F] Ikerbasque, Basque Foundation for Science, Bilbao, Spain. | |
dc.contributor.funder | This study was supported by a grant from “Plan Estatal de I+ D+ I 2013–2016, ISCIII-Subdirección de Evaluación y Fomento de la Investigación-Fondo Europeo de Desarrollo Regional (FEDER) (Grant PI13/00889)” and Marie Curie Actions, Career Integration Grant, European Commission (Grant CIG 631674). Joana Vitallé and Iñigo Terrén are recipients of a predoctoral contract funded by the Department of Education, Basque Government (PRE_2017_2_0242 and PRE_2018_1_0032). Joana Vitallé and Iñigo Terrén are recipients of a fellowship from the Jesús de Gangoiti Barrera Foundation (FJGB15/008 and FJGB17/003). Laura Tarancón-Díez was supported by Instituto de Salud Carlos III, PFIS (FI00/00431). Olatz Zenarruzabeitia is recipient of a postdoctoral contract funded by “Instituto de Salud Carlos III-Contratos Sara Borrell 2017 (CD17/0128)” and the European Social Fund (ESF)-The ESF invests in your future. Ezequiel Ruiz-Mateos is supported by Programa Nicolás Monardes, C0032-2017, Consejería de Salud y Bienestar Social, Junta de Andalucía. Francisco Borrego is an Ikerbasque Research Professor, Ikerbasque, Basque Foundation for Science. | |
dc.date.accessioned | 2022-09-22T10:35:55Z | |
dc.date.available | 2022-09-22T10:35:55Z | |
dc.date.issued | 2020-04-08 | |
dc.description.abstract | CD300a receptor is found on different CD8+ T cell subsets and its expression has been associated to a more cytotoxic molecular signature. CD300a has an important role in some viral infections and its expression levels are known to be modulated by human immunodeficiency virus (HIV)-1 infection on several cell types. The main objective of this work was to investigate CD300a expression and its regulation during HIV-1 specific CD8+ T cell responses. CD300a receptor expression was analysed by multiparametric flow cytometry on CD8+ T lymphocytes from HIV negative donors, naive HIV-1+ individuals and HIV-1+ subjects under suppressive combined antiretroviral therapy (cART). HIV-1 specific CD8+ T cell response was studied by stimulating cells with HIV-1 derived peptides or with a Gag HIV-1 peptide. Our results showed that HIV-1 specific CD8+ T cells expressing higher levels of CD300a were more polyfunctional showing an increased degranulation and cytokine production. Moreover, we observed an up-regulation of CD300a expression after Gag HIV-1 peptide stimulation. Finally, our results demonstrated an inverse correlation between CD300a expression on CD8+ T lymphocytes and HIV disease progression markers. In conclusion, CD300a expression is associated to a better and more polyfunctional HIV-1 specific CD8+ T cell response. | es_ES |
dc.description.version | Yes | es_ES |
dc.identifier.citation | Vitallé J, Terrén I, Gamboa-Urquijo L, Orrantia A, Tarancón-Díez L, Genebat M, et al. Polyfunctional HIV-1 specific response by CD8+ T lymphocytes expressing high levels of CD300a. Sci Rep. 2020 Apr 8;10(1):6070 | es_ES |
dc.identifier.doi | 10.1038/s41598-020-63025-4 | es_ES |
dc.identifier.essn | 2045-2322 | |
dc.identifier.pmc | PMC7142067 | |
dc.identifier.pmid | 32269232 | es_ES |
dc.identifier.uri | http://hdl.handle.net/10668/4112 | |
dc.journal.title | Scientific Reports | |
dc.language.iso | en | |
dc.page.number | 12 p. | |
dc.publisher | Springer Nature | es_ES |
dc.relation.publisherversion | https://www.nature.com/articles/s41598-020-63025-4 | es_ES |
dc.rights | Atribución 4.0 Internacional | * |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | HIV-1 | es_ES |
dc.subject | Cytokines | es_ES |
dc.subject | Peptides | es_ES |
dc.subject | CD300a receptor | es_ES |
dc.subject | T-Lymphocytes | es_ES |
dc.subject | Citocinas | es_ES |
dc.subject | Péptidos | es_ES |
dc.subject | Linfocitos T | es_ES |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Antiviral Agents::Anti-Retroviral Agents::Anti-HIV Agents | es_ES |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Biological Factors::Antigens::Antigens, Surface::Antigens, Differentiation::Antigens, CD | es_ES |
dc.subject.mesh | Medical Subject Headings::Anatomy::Cells::Blood Cells::Leukocytes::Leukocytes, Mononuclear::Lymphocytes::T-Lymphocytes::CD8-Positive T-Lymphocytes | es_ES |
dc.subject.mesh | Medical Subject Headings::Anatomy::Cells::Cells, Cultured | es_ES |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Intercellular Signaling Peptides and Proteins::Cytokines | es_ES |
dc.subject.mesh | Medical Subject Headings::Diseases::Immune System Diseases::Immunologic Deficiency Syndromes::HIV Infections | es_ES |
dc.subject.mesh | Medical Subject Headings::Organisms::Viruses::RNA Viruses::Retroviridae::Lentivirus::Lentiviruses, Primate::HIV::HIV-1 | es_ES |
dc.subject.mesh | Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans | es_ES |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Chemical Phenomena::Biochemical Phenomena::Biochemical Processes::Up-Regulation | es_ES |
dc.subject.mesh | Medical Subject Headings::Anatomy::Cells::Blood Cells::Leukocytes::Leukocytes, Mononuclear::Lymphocytes::T-Lymphocytes::T-Lymphocyte Subsets | es_ES |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Peptides | es_ES |
dc.title | Polyfunctional HIV-1 specific response by CD8+ T lymphocytes expressing high levels of CD300a | es_ES |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dspace.entity.type | Publication |